Article Details

Minerva Neurosciences Announces the Results of the Phase 3 Trial of Roluperidone for the ...

Retrieved on: 2021-05-11 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Minerva Neurosciences Announces the Results of the Phase 3 Trial of Roluperidone for the .... View article details on hiswai:

Excerpt

WALTHAM, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up